186 related articles for article (PubMed ID: 7053066)
41. Activation of adenylate cyclase by dopamine, GTP, NaF and forskolin in striatal membranes of neonatal, adult and senescent rats.
Nomura Y; Makihata J; Segawa T
Eur J Pharmacol; 1984 Nov; 106(2):437-40. PubMed ID: 6543337
[TBL] [Abstract][Full Text] [Related]
42. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ
J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
[TBL] [Abstract][Full Text] [Related]
44. Ontogenetic development of the striatal [3H]spiperone binding: regulation by sodium and guanine nucleotide in rats.
Nomura Y; Oki K; Segawa T
J Neurochem; 1982 Apr; 38(4):902-8. PubMed ID: 6174692
[TBL] [Abstract][Full Text] [Related]
45. Stimulatory action of lisuride on dopamine-sensitive adenylate cyclase in the rat striatal homogenate.
Azuma H; Oshino N
Jpn J Pharmacol; 1980 Oct; 30(5):629-39. PubMed ID: 7206370
[TBL] [Abstract][Full Text] [Related]
46. Guanine nucleotides distinguish between two dopamine receptors.
Creese I; Usdin T; Snyder SH
Nature; 1979 Apr; 278(5704):577-8. PubMed ID: 431724
[No Abstract] [Full Text] [Related]
47. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
Coupet J; Rauh CE
Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
[TBL] [Abstract][Full Text] [Related]
48. Age related differences in dopamine-stimulated adenylate cyclase sensitivity to "in vivo" chronic ethanol treatment.
Lucchi L; Govoni S; Trabucchi M
Alcohol; 1984; 1(4):263-7. PubMed ID: 6100231
[TBL] [Abstract][Full Text] [Related]
49. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
50. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
51. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
Howlett DR; Morris H; Nahorski SR
Br J Pharmacol; 1979 May; 66(1):136P. PubMed ID: 454928
[No Abstract] [Full Text] [Related]
52. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
[TBL] [Abstract][Full Text] [Related]
53. Endogenous components of the striatum confer dopamine-sensitivity upon adenylate cyclase activity: the role of endogenous guanyl nucleotides.
Chen TC; Cote TE; Kebabian JW
Brain Res; 1980 Jan; 181(1):139-49. PubMed ID: 7350949
[TBL] [Abstract][Full Text] [Related]
54. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
Roufogalis BD; Thornton M; Wade DN
Life Sci; 1976 Sep; 19(6):927-34. PubMed ID: 966971
[No Abstract] [Full Text] [Related]
55. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
Pedigo NW; Reisine TD; Fields JZ; Yamamura HI
Eur J Pharmacol; 1978 Aug; 50(4):451-3. PubMed ID: 699968
[No Abstract] [Full Text] [Related]
56. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
57. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
Miller RJ; Horn AS; Iversen LL
J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
[No Abstract] [Full Text] [Related]
58. Chronic lithium reduces [3H]spiroperidol binding in rat striatum.
Rosenblatt JE; Pert A; Layton B; Bunney WE
Eur J Pharmacol; 1980 Oct; 67(2-3):321-2. PubMed ID: 7461036
[No Abstract] [Full Text] [Related]
59. Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.
Gentleman S; Parenti M; Neff NH; Pert CB
Cell Mol Neurobiol; 1983 Mar; 3(1):17-26. PubMed ID: 6309392
[TBL] [Abstract][Full Text] [Related]
60. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.
Seeman P; Grigoriadis D
Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
